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Abstract. Mycosis fungoides is a cutaneous T-cell lymphoma, 
a subgroup of non-Hodgkin's lymphomas, characterized by 
skin infiltration and occasionally systemic involvement. The 
association of pregnancy and mycosis fungoides has not been 
described previously. A case of mycosis fungoides, stage IVb, 
in a pregnant woman is reported. Prior to pregnancy, the 
patient received adriamycin, cyclophosphamide, vincristine 
p r edn i so lone (CHOP) and b l e o m y c i n and total body 
irradiation. Around the concepcional period she presented a 
cutaneous relapse palliated with photon radiotherapy. No 
obstetrics complications were observed during gestation. At 
39 week's gestation a cesarean section was performed and a 
healthy 2900 g boy was delivered. Mycosis fungoides did not 
worsen during pregnancy and postpartum period. In conclusion 
mycosis fungoides did not adversely affect pregnancy outcome 
and gestation did not worsen the malignancy course. This case 
report may be valuable in managing patients with mycosis 
fungoides who are currently pregnant or are contemplating 
pregnancy. 
Case report 
A 28-year old woman, gravida 0, para 0, was diagnosed as 
having mycosis fungoides (MF) when she was 25. At initial 
diagnosis she presented with plaque skin disease and cutaneous 
tumors, and lymph nodes and bone marrow involvement (stage 
IVb). Six courses of CHOP regimen (adriamycin, cyclo­
phosphamide, vincristine and prednisolone) and bleomycin 
were administered. After one year the patient presented a 
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generalized cutaneous relapse which was successfully treated 
by total body irradiation with electron-beam radiotherapy 
(total dose of 3000 cGy). Eighteen months later a localized 
episode involving face and neck skin was again treated by 
electron-beam radiotherapy (2400 cGy). Three months before 
her first visit to our department, the patient had a new 
generalized relapse palliated with photon radiotherapy (2 
courses of 100 cGy each, one month apart) resulting in a 
partial remission of the cutaneous lesions. At that first visit, 
she referred to amenorrhea for the last three months and the 
ultrasonographic diagnosis of a 10 week's gestation was 
made. Therefore, conception probably occurred at the time of 
photon radiotherapy. 
Laboratory data, ultrasonography and non-stress test 
controls were all normal. At 39 week's gestation the patient 
presented with p r ema tu re rupture of membranes and 
antibiotic therapy was prescribed. After 48 h, delivery was 
induced and 11 h later a cesarean section was performed. 
A hea l thy 2900 g boy was born wi thout congeni ta l 
malformations. Apgar scores were 8 and 9 at 1 and 5 min, 
respectively. The histopathologic examination of the placenta 
did not reveal any abnormality. Postoperative recovery was 
complicated by an abscess of the surgical incision which 
resolved with drainage and antibiotics. The patient was 
discharged in good condition 12 days after surgery. 
During the whole gestation and postpartum period MF 
did not worsen (Figs. 1 and 2). No specific therapy was 
necessary to treat the residual lesions. 
At age 9 months , the infant showed normal general 
development. 
Discussion 
Incidence of malignancies in pregnant women is not higher 
than the observed in non-pregnant ones. Malignant 
lymphomas are a heterogeneous group of lymphoproliferative 
disorders that appear in 1/1000-6000 gestations (1), and 
represent in frequency the fourth observed neoplasm during 
pregnancy (2) . Hodgkin 's disease is the most frequent 
lymphoma observed in pregnancy (1), whereas non-Hodgkin's 
lymphomas (NHL) have been only reported in 36 cases (3). 
Cutaneous T-cell lymphomas are a subgroup of NHL, MF 
and Sézary syndrome being the most common ones (4). 
MF is a disease characterized by infiltration of the skin 
with malignant T-lymphocytes as the predominant feature. 
The inicial course is usually quite indolent with slow 
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Figure 1. Mycosis fungoides generalized residual lesions after photon radio­
therapy at 10 week's gestation. 
Figure 2. Aspect of cutaneous lesions prior to delivery, showing no sub­
stantial changes during pregnancy. 
progressive cutaneous involvement of the skin with paches, 
p laques , tumors or diffuse ery t roderma. Never theless , 
malignant T-lymphocytes may infiltrate the T-dependent 
regions of lymph nodes, and disseminate widely to other 
visceral structures. This condition is generally associated 
with short survival times (5). 
To the best of our knowledge this is the first case ever 
reported of MF and pregnancy. This rare association can be 
explained first, by the very low frequency (0.2-0.4 cases per 
100000 population) of MF, second by the sex distribution 
(twice as frequent in men than in women) and finally, by the 
age of presentation (usually over 50) (6). 
The interaction of pregnancy and NHL is difficult to 
assess because of the relative paucity of cases (7,8). Although 
some authors have suggested than NHL in pregnancy is most 
c o m m o n l y assoc ia ted with agg re s s ive h is to logy and 
disseminated disease (9,10), others have found no influence 
on the course of treated or untreated NHL (8). On the other 
hand, NHL usually have an adverse effect on pregnancy (8). 
In our case, in spite of the advanced disease, poor survival 
prognosis , total body irradiation and chemotherapeutic 
treatment, the patient became pregnant three years after the 
diagnosis of MF. Moreover, around the conceptional period 
she presented a generalized cutaneous relapse pallied by total 
body photon radiotherapy. Althougth radiation treatment was 
administered early in pregnancy, the fetus did not became 
affected since most of this type of energy is absorbed in the 
first 5-10 mm of tissue. 
Albeit the effects of NHL on the pregnancy are often 
harmful, and in spite of the lymph nodes and bone marrow 
involvement, in this advanced case of MF, whole gestation 
progressed normally. Furthermore, pregnancy did not worsen 
MF evolutive course and the patient did not require additional 
antineoplastic treatment. 
Finally, the facts that both etiopathogenic associations 
between MF and human T-cell lymphotropic virus (HTLV) 
types I, II, and V (11,12), and clusters of MF cases within 
families have been described (13), lead to consider the 
possibility of HTLV vertical transmission in the reported 
case. Although apparently the infant had grown up normally 
until age 15 months, a careful follow-up is needed to rule out 
that possibility. 
In summary, MF did not adversely affect pregnancy 
outcome, and gestation did not worsen the malignancy 
course. Although therapeutic abortion has been recommended 
for patients with NHL who present with aggressive histology 
and more advanced disease (stages II, III, IVA, or IVB) in 
the first trimester (8), the favorable outcome in our case may 
be valuable in counseling patients with MF who are currently 
pregnant or are contemplating pregnancy. Moreover, since 
several studies have suggested that viral agents may play a 
role in the etiology of MF, vertical transmission cannot be 
excluded and follow-up of the newborns is warranted. 
References 
1. Ward FT and Weiss RB: Lymphoma and pregnancy. Semin 
Oncol 16: 397-409, 1989. 
2. Haas JF: Pregnancy in association with a newly diagnosed 
cancer: a population-based epidemiologic assessment. Int J 
Cancer 34: 229-235, 1984. 
ONCOLOGY REPORTS 8: 197-199, 2001 199 
3. Spitzer M, Citron M, Hardi CF and Saxe B: Non-Hodgkin's 
lymphoma during pregnancy. Gynecol Oncol 43: 309-312, 
1991. 
4. Weinstock MA and Horm JW: Mycosis fungoides in the United 
States, increasing incidence and descriptive epidemiology. 
JAMA 260: 42-46, 1988. 
5. Graham SJ, Sharpe RW, Steinberg SM, Cotelingam JD, 
Sausville EA and Foss FM: Pronostic implications of a bone 
marrow histopathologic classification syatem in mycosis 
fungoides and the Sézary syndrome. Cancer 72: 726-734, 
1993. 
6. Kuze! TM , Roenigk HH and Rosen ST: Mycosis fungoides and 
the Sézary syndrome: a review of pathogenesis, diagnosis, and 
therapy. J Clin Oncol 9: 1298-1313, 1991. 
7. Avilés A, Diaz-Maqueo JC, Torras V, Garcia EL and Guzman R: 
Non-Hodgkin's lymphomas and pregnancy: presentation of 16 
cases. Gynecol Oncol 37: 335-337, 1990. 
8. Ward FT and Weiss RB: Lymphoma and pregnancy. Semin 
Oncol 16: 397-409, 1989. 
9. Ioachim HL: Non-Hodgkin's lymphoma in pregnancy: three 
cases and review of the literature. Arch Pathol Lab Med 109: 
803-809, 1985. 
10. Steiner-Saltz D, Yahalom J, Samuelov A, et al: Non-Hodgkin's 
lymphoma associated with pregnancy: a report of six cases, with 
a review of the literature. Cancer 56: 2087-2091, 1985. 
11. Zucker-Franklin D, Hooper WC and Evatt BL: Human lympho-
tropic retroviruses associated with mycosis fungoides: evidence 
that human T-cell lymphotropic virus type II (HTLV-II) as well 
as HTLV-I may play a role in the disease. Blood 80: 1537-1545, 
1992. 
12. Fine RM: HTLV-V: a new human retrovirus associated with 
cutaneous T-cell lymphoma (mycosis fungoides). Int J Dermatol 
27: 473-474, 1988. 
13. Sandbank M and Katzenenellenbogen I: Mycosis fungoides of 
prolonged duration in siblings. Arch Dermatol 98: 620-627, 
1968. 
